Skip to content

Complications, Outcomes and Revisions Following Hiatal Hernia Repair With MIROMESH

Complications and 1-Year Outcomes Following Hiatal Hernia Repair With MIROMESH a Novel, Highly Vascular, Porcine Derived, Biologic Matrix

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03735862
Enrollment
85
Registered
2018-11-08
Start date
2017-06-01
Completion date
2018-10-01
Last updated
2019-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux, GERD, Hiatal Hernia With Gastroesophageal Reflux Disease

Brief summary

Investigator will identify a consecutive cohort of patients who have undergone a hiatal hernia repair and are at least 6 months post index procedure.

Detailed description

Planned Sample Size: At minimum of 70 consecutive subjects at least 6-months post-index procedure Study Population: A consecutive cohort of patients who have undergone a hiatal hernia repair with MIROMESH. Primary Objective: Characterize the procedural and early post-operative safety profile of MIROMESH when used as reinforcement in hiatal hernia repair. Secondary Objectives A retrospective chart review will identify the appropriate cohort with a prospective follow-up survey to acquire safety and outcome information. A retrospective chart review of appropriate subjects. Data to be acquired will be: Preoperative - Chart Review * Gender * Date of birth * Weight * Body Mass Index * Specific diagnosis * DeMeester Score * 24 hour pH test (% acid exposure in 24 hours) * Gastroesophageal Reflux Disease Health Related Quality of Life (GERD-HRQL) Score Peri-operative Preoperative - Chart Review * Date of surgery * Number of stitches used to close wound * Paraesophageal hernia type * Mesh shape * Mesh size used * Attachment technique * Length of stay * Complications Post-Operative (With-in 1 month of surgery) Preoperative - Chart Review * Complications (Mesh related) * Complications (procedure related) * Prolonged dysphagia (Y/N) * Stenosis (Y/N) * Dilations (Y/N) * Esophagogastroduodenoscopy or Upper gastrointestinal series documented hernia recurrence * GERD-HRQL Score Prospective institutional review board approved Follow-Up Telephone Interview * Have you had a revision surgery? * GERD-HRQL Score * How satisfied are you with the procedure? * Have you used proton pump inhibitors in the last 3 months * How likely are you to recommend this procedure to a loved one?

Interventions

BIOLOGICALHepatic derived surgical matrix

Hiatal hernia repair with MIROMESH

Sponsors

Miromatrix Medical Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Had a hiatal hernia repair with MIROMESH greater than 6 months prior to study

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frameDescription
Number of Subjects Who Required a Revision of the Index Surgery.6-18 months post index procedurePatient self-report if they had a revision or other laparoscopic surgery following index procedure.

Secondary

MeasureTime frameDescription
Gastroesophageal Reflux Disease Health Related Quality of Life Score (GERD-HRQL)6-18 months post index procedureThe GERD-HRQL score assess the severity of GERD symptomatic and impact on the subjects quality of life. The score is comprised of 10 questions whose answers are summed for the final score. THe score can range from 0 to 50, with 50 being the worst and 0 meaning no impact.
Medication Use6-18 months post index procedureUse of PPIs in 3-months prior to follow-up interview

Other

MeasureTime frameDescription
Satisfaction With Procedure6-18 Months post index procedurePatients reported their satisfaction with the procedure as Dissatisfied, Neutral, or Satisfied.
Likelihood to Recommend6-18 Months post index procedurePatients were asked to report how likely they would be to recommend this procedure to a friend or loved one with the same condition. Report was based on a scale of 1 (not at all likely) to 10 (very likely).

Countries

United States

Participant flow

Recruitment details

A consecutive cohort of patients who underwent a hiatal hernia repair between 1 Nov 2015 and 1 Mar 2017 at the principle investigator's private practice were identified. Patients were contacted by phone and asked if they were willing to participate. If so they were consented and enrolled.

Pre-assignment details

12 patients declined participation or could not be contacted. These were included in the baseline analysis.

Participants by arm

ArmCount
Observations Group
Patients who have undergone a hiatal hernia repair with MIROMESH. Hepatic derived surgical matrix: Hiatal hernia repair with MIROMESH
85
Total85

Baseline characteristics

CharacteristicObservations Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
22 Participants
Age, Categorical
Between 18 and 65 years
63 Participants
Age, Continuous55.9 Years
STANDARD_DEVIATION 12.7
GERD-HRQL27.7 Score
STANDARD_DEVIATION 9.3
Proton Pump Inhibitor Use
No
12 Participants
Proton Pump Inhibitor Use
Yes
73 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
85 Participants
Sex: Female, Male
Female
55 Participants
Sex: Female, Male
Male
30 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 73
other
Total, other adverse events
3 / 73
serious
Total, serious adverse events
0 / 73

Outcome results

Primary

Number of Subjects Who Required a Revision of the Index Surgery.

Patient self-report if they had a revision or other laparoscopic surgery following index procedure.

Time frame: 6-18 months post index procedure

Population: 12 patients declined participation or could not be contacted.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Observations GroupNumber of Subjects Who Required a Revision of the Index Surgery.0 Participants
Secondary

Gastroesophageal Reflux Disease Health Related Quality of Life Score (GERD-HRQL)

The GERD-HRQL score assess the severity of GERD symptomatic and impact on the subjects quality of life. The score is comprised of 10 questions whose answers are summed for the final score. THe score can range from 0 to 50, with 50 being the worst and 0 meaning no impact.

Time frame: 6-18 months post index procedure

Population: 12 patients declined participation or could not be contacted.

ArmMeasureValue (MEAN)Dispersion
Observations GroupGastroesophageal Reflux Disease Health Related Quality of Life Score (GERD-HRQL)7.1 ScoreStandard Deviation 8.1
Comparison: Difference between baseline and follow-upp-value: <0.001t-test, 1 sided
Secondary

Medication Use

Use of PPIs in 3-months prior to follow-up interview

Time frame: 6-18 months post index procedure

Population: 12 patients declined participation or could not be contacted. One patient did not answer.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Observations GroupMedication UseYes7 Participants
Observations GroupMedication UseNo65 Participants
Comparison: Difference between baseline and follow-upp-value: <0.0001McNemar
Other Pre-specified

Likelihood to Recommend

Patients were asked to report how likely they would be to recommend this procedure to a friend or loved one with the same condition. Report was based on a scale of 1 (not at all likely) to 10 (very likely).

Time frame: 6-18 Months post index procedure

Population: 12 patients declined participation or could not be contacted.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Observations GroupLikelihood to Recommend<=33 Participants
Observations GroupLikelihood to Recommend>= 4 - <= 76 Participants
Observations GroupLikelihood to Recommend>=864 Participants
Other Pre-specified

Satisfaction With Procedure

Patients reported their satisfaction with the procedure as Dissatisfied, Neutral, or Satisfied.

Time frame: 6-18 Months post index procedure

Population: 12 patients declined participation or could not be contacted.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Observations GroupSatisfaction With ProcedureSatisfied63 Participants
Observations GroupSatisfaction With ProcedureNeutral6 Participants
Observations GroupSatisfaction With ProcedureDissatisfied4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026